Drug Profile
PTI 110
Alternative Names: AA-amyloidosis therapeutic - ProteoTech; PTI-110; SystebrylLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator ProteoTech
- Class Small molecules
- Mechanism of Action Amyloid fibril protein AL inhibitors; Amyloid inhibitors; Serum amyloid A protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Amyloidosis